Study Name Principal Investigator
: Efficacy of Virtual Simulation Training in Medical School Curriculum Nussbaum, Julian
(5F9003) A Phase 1b/2 Trial of Hu5F9-G4 in Combination with Rituximab or Rituximab + Chemotherapy in Patients with Relapsed/ Refractory B-cell Non-Hodgkin’s Lymphoma Bryan, Locke
(ACCUTE) Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study of AB103 as Compared to Placebo in Patients with Necrotizing Soft Tissue Infections (NSTI) ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections) Young, Lester
(ADCT-402-103) A Phase 1b Open-Label Study to Evaluate the Safety and Antitumor Activity of Loncastuximab Tesirine and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Bryan, Locke
(ALA Cogn) Effect of 6 weeks of Alpha-Lipoic Acid Supplementation on Cognitive and Vascular Function in Older Adults Robinson, Vincent
(ALPINE2) Randomized, Double-Blind, Phase 3B Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75 mg Powder and Solvent for Nebulizer Solution / Aztreonam for Inhalation Solution (AZLI) in Pediatric Subjects with Cystic Fibrosis (CF) and New Onset Respiratory Tract Pseudomonas aeruginosa (PA) Infection/Colonization [Aztreonam Lysine for Pseudomonas INfection Eradication 2 (ALPINE 2) Study] McKie, Kathleen
(APOLLO) The APOL1 Long-term Kidney Transplantation Outcomes Network- APOLLO Study Gani, Imran
(ASCEND-ID) 52 week open-label (sponsor blind), randomized, active controlled, parallel group, multi-center study to evaluate the efficacy and safety of Daprodustat compared to recombinant human erythropoietin in subjects with anemia associated with chronic kidney disease who are initiating dialysis Mulloy, Laura
(ASPIRE) Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery Nichols, Fenwick
(Asteroid 6) An open-label, parallel-group, randomized, multicenter study to assess the safety and efficacy of vilaprisan in subjects with uterine fibroids versus standard of care Theisen, John Graham
(Bayer Elagolix) A randomized, double-blind, open for active comparator, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of three different doses of P2X3 antagonist (BAY 1817080) versus placebo and elagolix 150 mg in women with symptomatic endometriosis Brakta, Soumia
(BCC015) Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma McDonough, Colleen
(BIO101-COVA) Adaptive design phase 2 to 3, randomized, double-blind, multicenter, to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of BIO101 in the prevention of the respiratory deterioration in hospitalized patients with COVID-19 pneumonia (severe stage) Islam, Shaheen
(Blue-C Cologuard) Clinical Validation of an Optimized Multi-Target Stool DNA (mtsDNA 2.0) Test, for Colorectal Cancer Screening “Blue-C” Vega, Kenneth
(CD12) A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients with Severe or Critical Coronavirus Disease 2019 (COVID-19) Islam, Shaheen
(CONGA) COVID-19 Neurological and Molecular Prospective Cohort Study in Georgia Rutkowski, Elizabeth
(CONNECT-HF) Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure Dunlap, Stephanie
(DCRI Carra)The Carra Registry: Observational Study of Pediatric Rheumatic Diseases Patel, Julisa
(EB05) A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Eb05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients with Covid-19 Taskar, Varsha
(Edelweiss) A Phase 3 multicenter, randomized, double-blind, placebo-controlled, clinical study to assess the efficacy and safety of linzagolix in subjects with moderate to severe endometriosis-associated pain Brakta, Soumia
(Eisai 238) An open-label study with an extension phase to evaluate the pharmacokinetics of perampanel (E2007) oral suspension when given as an adjunctive therapy in subjects from 1 month to less than 24 months (<2 years) of age with epilepsy Park, Yong
(Gel) A Two-part, Multicenter, Dose-titration Study Evaluating the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Oxybutynin Chloride 10% Gel for the Treatment of Detrusor Overactivity Associated With a Neurological Condition in Pediatric Patients Morganstern, Bradley
(GRI RIC) Chronic Remote Ischemic Conditioning in Vascular Cognitive Impairment: A Dose Escalation Study Bruno, Askiel
(Heart-FID) A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency Dunlap, Stephanie
(HLA-G) To Develop and Optimize Innovative Methods and Therapies that Prevent Rejection and Prolong Transplant Survival in Patients Mulloy, Laura
(In vitro D-dimer) The Diagnostic Utility of the in-vitro Provoked D dimer test in patients with suspected thromboembolism, either pulmonary embolism (PE) or deep venous thrombosis (DVT) or both Robinson, Vincent
(Inspire Adhere) Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry Reyes Gelves, Camilo
(KEYLYNK-010) A Phase 3, Randomized Open-label Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) Who are Unselected for Homologous Recombination Repair Defects and Have Failed Prior Treatment with One Next-generation Hormonal Agent (NHA) and Chemotherapy Parikh, Jigarkumar
(KEYNOTE-641) A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Parikh, Jigarkumar
(KEYNOTE-921) A Phase 3, Randomized, Double-blind Study of Pembrolizumab (MK-3475) Plus Docetaxel Plus Prednisone versus Placebo Plus Docetaxel Plus Prednisone in Participants with Chemotherapy-naïve Metastatic Castration-Resistant Prostate Cancer (mCRPC) who have Progressed on a Next Generation Hormonal Agent (NHA) Parikh, Jigarkumar
(Lionheart21) A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of NPC-21 for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection Mallavarapu, Ravi
(Lung Nodule) A Study to Evaluate a Panel of Blood Biomarkers for Use in Patients Undergoing Evaluation for Lung Cancer, Onc-Ln-04 Islam, Shaheen
(MASTERS-2) MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study Switzer, Jeffrey
(MEDLEY) A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children Patel, Pinkal
(MELODY) A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants Sapp, Erica
(MET42) Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers Pierce, Rebecca
(MK7339-002) A Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer Nayak-Kapoor, Asha
(MSK-002 MG) A Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Amifampridine Phosphate in Patients with MuSK Antibody Positive Myasthenia Gravis, and a Sample of AChR Antibody Positive Myasthenia Gravis Patients Pruitt, J. Ned
(Natural History) A Natural History Study of Patients with Biopsy-proven Focal Segmental Glomerulosclerosis and Proteinuria Who Are of Recent African Ancestry or Have 2 APOL1 Risk Alleles Mulloy, Laura
(NO1269 Absence) Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel Group Multicenter Study with a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age with Childhood Absence Epilepsy or Juvenile Absence Epilepsy Park, Yong
(NOWS) A Phase II, multicenter, double blind, double dummy, randomized, two- arm parallel study to evaluate the efficacy, safety and pharmacokinetics of CHF6563 in babies with Neonatal Opioid Withdrawal Syndrome Stansfield, Brian
(OKRA) Evaluation of Patient Outcomes From the Kidney Allograft Outcomes Allosure Registry Gani, Imran
(OPTISON) A Phase 4, Open-Label, Non-randomized, Multicenter Study to Evaluate Safety and Efficacy of Intravenous Administration of OPTISON™ for Contrast-Enhanced Echocardiography in Pediatric Patients Shivaram, Pushpa
(Oxbryta) An Open-label, Expanded Access Protocol for Pediatric Patients with Sickle Cell Disease Who Have No Alternative Treatment Options Mian, Amir
(Paisley) A Phase 2, Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of BMS-986165 with Background Treatment in Subjects with Lupus Nephritis Mulloy, Laura
(PERFUSE) AEGIS-II: A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome Arora, Vishal
(PISCES III Stroke) A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in subjects with Disability Following an Ischemic Stroke (PISCES III) Switzer, Jeffrey
(Pluristem) A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of severe COVID-19 Bechara, Rabih
(Premier LGS C001) Phase I, Open-Label, Pharmacokinetic, Dose-Escalation Study of Carisbamate in Adult and Pediatric Subjects with Lennox-Gastaut Syndrome Park, Yong
(ROP) Randomized, Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients with Retinopathy of Prematurity Espinosa, Diego
(RWE Registry) Registry to Evaluate Effectiveness and Safety of the Nanoknife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma Kruse, Edward
(SAGE) A Study of Brexanolone for Acute Respiratory Distress Syndrome due to Covid-19 Healy, William
(SASS) Randomized trial of Single-incision versus Retropubic Mid-Urethral Sling (Solyx™) for Concomitant Management of Stress Urinary Incontinence during Minimally Invasive Sacrocolpopexy Henley, Barbara
(SATURN) Statins Use in Intracerebral Hemorrhage Patients Siddu, Mithilesh
(Savara) A Phase III, randomized, double-blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients McKie, Kathleen
(SMART-MSP) Strategic MAnagement to Improve CRT Using Multi-Site Pacing, Post Approval Study Hreibe, Haitham
(STOP 2) Standardized Treatment of Pulmonary Exacerbations II Forseen, Caralee
(STRUCTURE) A proSpecTive, Randomized, controlled, single-blind, dose-finding, mUlti-Center, parallel group study of the safeTy and efficacy of KUR-113 Bone Graft (TGplPTH1-34 in fibrin) versus local autograft for the treatment of patients undergoing single-level transforaminal lumbar intErbody fusion (the STRUCTURE study) DeVine, John
(TDE-HF-301) A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects with Pulmonary Hypertension (PH) in Heart Failure with Preserved Ejection Fraction (HFpEF) McDonough, Clark
(The PROMISE Study) A prospective study to evaluate biological and clinical effects of significantly corrected CFTR function Taskar, Varsha
(TRANSFORM-HF) Torsemide comparison with furosemide for management of heart failure Dunlap, Stephanie
(Windtree) A Multicenter, Single-Treatment Study to Assess the Safety and Tolerability of Lyophilized Lucinactant in Adults with COVID-19 Associated Acute Lung Injury Gonzales, Joyce
1450-BJI-205: Randomized Open-label Active-controlled Study to Assess the Safety, Tolerability and Efficacy of Afabicin IV/oral in the Treatment of Patients with Bone or Joint Infection due to Staphylococcus Vazquez, Jose
1951-CL-0101 A Phase 1b Study of ASP1951, a GITR Agonistic Antibody, as a Single Agent and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors Ghamande, Sharad
20-041-NCP: BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer (BESPOKE CRC) Nayak-Kapoor, Asha
4010-03-001 / ENGOT EN-6 / GOG-3031: A phase 3, randomized, double-blind, multicenter study of dostarlimab (TSR-042) plus carboplatin-paclitaxel versus placebo plus carboplatin-paclitaxel in patients with recurrent or primary advanced endometrial cancer (RUBY) Ghamande, Sharad
4020-01-001: A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an anti-TIM-3 Monoclonal Antibody, in Patients with Advanced Solid Tumors (AMBER) Abdel Karim, Nagla
A Double Blind, Randomized, Sham-procedure controlled, Parallel group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cell (CEP-41750) in Patients with Chronic Heart Failure Due to Left Ventricular Systolic Dysfunction of Either Ischemic or Non-ischemic Etiology Weintraub, Neal
A multi-center, randomized, controlled trial of Brexpiprazole for the treatment of co-occurring schizophrenia and substance use disorder. McEvoy, Joseph
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications Kota, Vamsi
A Multicenter Pilot Study to Evaluate Intermediate Health and Social Outcomes in Hospital-Based Violence Intervention Programs Medeiros, Regina
A Multicenter, Randomized, Subject-blinded, Investigator-blinded, Placebo-controlled, Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Rozanolixizumab in Subjects with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Rivner, Michael
A Phase 1 / 2, Open-Label, Multiple Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion to Second-Line Cervical Cancer Ghamande, Sharad
A PHASE 1/2A, MULTICENTER, OPEN-LABEL STUDY OF LYC-55716 IN ADULT SUBJECTS WITH LOCALLY ADVANCED OR METASTATIC CANCER Ghamande, Sharad
A Phase 2, 12-week, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of 3Dose levels of TAK-831 in Adjunctive Treatment of Adult Subjects with Negative Symptoms of Schizophrenia McEvoy, Joseph
A phase 2, Multicenter, Open-Label Study to Assess PK/PD of SEG101 (crizanlizumab), with or without Hydroxyurea/Hydroxycarbamide, in Adult Sickle Cell Patients with Vaso-Occlusive Crisis Kutlar, Abdullah
A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS) McEvoy, Joseph
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGCETACOPLAN IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) Rivner, Michael
A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients With Generalized Myasthenia Gravis Rivner, Michael
A Phase 2a Open-Label, Multi-Center Study to Evaluate the Safety and Tolerability of Multiple Doses of AT-1501 in Adults with ALS Rivner, Michael
A PHASE 2B/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12 MONTH CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF MN-166 (IBUDILAST) FOLLOWED BY AN OPEN-LABEL EXTENSION IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS Rivner, Michael
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Patients With Sickle Cell Disease Kutlar, Abdullah
A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, 27-WEEK TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF TWO FIXED DOSES OF TAVAPADON IN EARLY PARKINSON’S DISEASE (TEMPO-1 TRIAL) Morgan, John
A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, FLEXIBLE-DOSE, 27-WEEK TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF TAVAPADON AS ADJUNCTIVE THERAPY FOR PARKINSON’S DISEASE IN LEVODOPA-TREATED ADULTS WITH MOTOR FLUCTUATIONS (TEMPO-3 TRIAL) Morgan, John
A Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects with Generalized Myasthenia Gravis Rivner, Michael
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects with Generalized Myasthenia Gravis Rivner, Michael
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation Forseen, Caralee
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis Rivner, Michael
A PHASE 3, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY Ray, Chadburn
A Phase 3, randomized, placebo-controlled, double-blind clinical study of pembrolizumab (MK-3475) with or without lenvatinib (E7080/MK-7902) to evaluate the safety and efficacy of pembrolizumab and lenvatinib as 1L intervention in a PD-L1 selected population of participants with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) (LEAP-010). Guddati, Achuta
A phase Ib /II trial of pembrolizumab and idelalisib in patients with non-small cell lung cancer (NSCLC) who have failed immune checkpoint inhibitor Hao, Zhonglin
A Phase III, Randomized, Multicenter, Parallel-group, Open- Label Study Evaluating the Efficacy, Safety, and Tolerability of Long-Acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch from an Integrase Inhibitor Single Tablet Regimen in HIV-1 Infected Antiretroviral Therapy Naive Adult Participants Newman, Cheryl
A Prospective Observational Multicenter Study of HF10 Therapy in Patients Who Previously Failed Traditional SCS (RENEW) Dua, Anterpreet
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed By Electroporation With Cellectra™ 5PSP For The Treatment Of HPV-16 And/Or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) Of The Cervix Rungruang, Bunja
A Randomized Controlled Trial of Adjunctive Siltuximab in Schizophrenia Miller, Brian
A Randomized Controlled Trial of Adjunctive Tocilizumab in Schizophrenia Miller, Brian
A RANDOMIZED, DOUBLE-BLIND, MULTICENTER,PLACEBO-CONTROLLED PHASE 3 STUDY WITH OPEN-LABEL PERIOD TO EVALUATE THE EFFICACY AND SAFETY OF INEBILIZUMAB IN ADULTS WITH MYASTHENIA GRAVIS Rivner, Michael
A Randomized, Double-blind, Placebo-Controlled, 2-Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients With Cognitive Impairment and an Elevated Risk of Falls Morgan, John
A randomized, multicenter, active-comparator controlled, open-label trial to evaluate efficacy and safety of oral, twice daily LNP023 in adult patients with PNH and residual anemia, despite treatment with an intravenous anti-C5 antibody Kutlar, Abdullah
A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults with Severe Sickle Cell Disease Kota, Vamsi
A Study to Explore the Incidence of Influenza and RSV in Adults Hospitalized with Acute Respiratory Tract Infection MacArthur, Rodger
A011106; ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: a phase III study Ghamande, Sharad
A011401; Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer Ghamande, Sharad
A011502: A randomized phase III double blinded placebo-controlled trial of aspirin as adjuvant therapy for node-positive, HER2 negative breast cancer: the ABC trial Ghamande, Sharad
A191402CD; TESTING DECISION AIDS TO IMPROVE PROSTATE CANCER DECISIONS FOR MINORITY MEN Ghamande, Sharad
ABL001E2201 (ASC4MORE): A phase 2, multi-center, open-label, randomized study of oral asciminib added to imatinib versus continued imatinib versus switch to nilotinib in patients with CML-CP who have been previously treated with imatinib and have not achieved deep molecular response Cortes, Jorge
Acceptance and Commitment Therapy vs. Supportive Psychotherapy with Cystic Fibrosis Patients Drescher, Christopher
Accuracy of a 3D Scanning Software to Identify Facial Features: A Prospective Instrument to Predict Difficult Airway Rocuts, Klifford
ACTIV-4C: A multicenter, adaptive, prospective, randomized trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge (Short title: COVID-19 Post-hospital Thrombosis Prevention Study) Vazquez, Jose
Actuate 1901: Phase 2 study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3) inhibitor, as a single agent or combined with Ruxolitinib, in patients with myelofibrosis Cortes, Jorge
ADXS001-04: Phase 1-2 Study of MEDI4736 Alone or In Combination with ADXS11-001 In Recurrent/Persistent or Metastatic Cervical or HPV+ Head & Neck Cancer Ghamande, Sharad
ALKS 4230-001: A Phase 1/2 Study of ALKS 4230 Administered Subcutaneously as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors- ARTISTRY-2 (001) Nayak-Kapoor, Asha
Amifampridine for the Treatment of Transient Vocal Weakness after OnabotulinumtoxinA Injection for Spasmodic Dysphonia Rivner, Michael
AML003 (ARMADA 2000): Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of CPI-613® (devimistat) in Combination with High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) therapy and control sub-groups: combination of Mitoxantrone, Etoposide and Cytarabine (MEC) and combination of Fludarabine, Cytarabine, and Filgrastim (FLAG) in Older Patients (? 50 years) with Relapsed/Refractory Acute Myeloid Leukemia (AML) Cortes, Jorge
An Objective Tool to Aid Diagnosis of PTSD and Evaluate Treatment outcome Vazdarjanova, Almira
An Observational Registry of Abatacept in Patients with Juvenile Idiopathic Arthritis Patel, Julisa
AN OPEN-LABEL EXTENSION STUDY TO EVALUATE ROZANOLIXIZUMAB IN STUDY PARTICIPANTS WITH GENERALIZED MYASTHENIA GRAVIS Rivner, Michael
An Open-label, Randomized, Phase 2/3 Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction of Clinical Benefit With First-line Chemotherapy Plus Pembrolizumab in Participants With Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (TNBC) (KEYLYNK-009) (MK7339-009) Krutchik, Allan
Antibodies in Amyotrophic Lateral Sclerosis Rivner, Michael
APX001-201: An Open-Label Study to Evaluate the Efficacy and Safety of APX001 in Non-Neutropenic Patients with Candidemia, with or without Invasive Candidiasis, Inclusive of Patients with Suspected Resistance to Standard of Care Antifungal Treatment Chao, Andrew
Assessment and Validation of Electronic Gas and Bloating Diary Rao, Satish
Assessment of Daily Electronic Stool Diary Rao, Satish
Assessment of Immune Cell function of kidney and kidney pancreas transplant recipients. A marker of strength of immunosuppression resulting from maintenance therapy after transplant: A Single Center Experience MIRZA, AHMAD
ATHN 10 – Leveraging the ATHNdataset to Document the State of Rare Coagulation Disorders in the United States Kutlar, Abdullah
Autonomic Nervous System Response to Transcranial Magnetic Stimulation in those with Major Depressive Disorder (ANS-TMS) Rosenquist, Peter
AVA-CIT-330: A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Active Non-Hematological Cancer Ghamande, Sharad
Before, During, and After: The Effects of Intermittent Fasting without Calorie Restriction on Adults with High BMI Cassel, Jennifer
Biomarkers and Therapies for Cancer (BAT Cancer) McIndoe, Richard
Body Composition Changes among Students Enrolled in Activity Courses Ruiz-Ramie, Jonathan
BP1002-101-Lymph: A Phase 1 Clinical Trial to Study the Safety, Pharmacokinetics, and Efficacy of BP1002 (L-Bcl-2) Antisense Oligonucleotide in Patients with Advanced Lymphoid Malignancies Bryan, Locke
Brain Vascular Malformation Consortium (BVMC3) Project 3: Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia Gossage, James
Breast and Ovarian Cancer in African American Women: Intergenerational Cancer Prevention Vernon, Marlo
C-145-04: A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety Using Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients with Recurrent, Metastatic or Persistent Cervical Carcinoma Ghamande, Sharad
C3FIT (Coordinated, Collaborative, Comprehensive, Family-Based, Integrated, and Technology-Enabled Care): A Comparative Effectiveness Randomized Trial to Improve Stroke Care Delivery Switzer, Jeffrey
CA 209-77T A Phase 3, Randomized, Double-blind Study of Neoadjuvant Chemotherapy plus Nivolumab versu Neoadjuvant Chemotherapy plus Placebo, followed by Surgical Resection and Adjuvant Treatment with Nivolumab or Placebo for Participants with Resectable Stage II-IIIB Non-small Cell Lung Cancer (Checkmate 77T, CHECKpoint pathway and nivoluMAb clinical Trial Evolution 77T) Abdel-Karim, Nagla
CA209-73L: A Phase 3, Randomized, Open Label Study to Compare Nivolumab plus Concurrent Chemoradiotherapy (CCRT) followed by Nivolumab plus Ipilimumab or Nivolumab plus CCRT Followed by Nivolumab vs CCRT followed by Durvalumab in Previously Untreated, Locally Advanced Non-small Cell Lung Cancer (LA NSCLC) Raval, Girindra
CC-16047: A Phase I/II Trial Of Pembrolizumab (MK-3475) And Poly-ICLC (Hiltonol®) In Patients With Metastatic Mismatch Repair-Proficient (MRP) Colon Cancer Nayak-Kapoor, Asha
CDX1140-01: A Phase 1 Study of CDX-1140, a Fully Human Agonist anti-CD40 Monoclonal Antibody, as Monotherapy or in Combination in Patients with Advanced Malignancies Kota, Vamsi
Cervical Diverticulum Prospective, Multi-Institutional Study Proposal Postma, Gregory
Changes in Psychological Flexibility, Suicidality, and Parenting in DBT for Adolescents Skills Group Participants Drescher, Christopher
Childhood Stress and Adult Physiology Breithaupt, Rebekah
Clozapine versus Olanzapine for the Treatment of Co-Morbid Psychotic and Substance Use Disorders McEvoy, Joseph
CLR_15_03: A Two-Part Phase 1/2 Study to Determine Safety, Tolerability, Pharmacokinetics, and Activity of K0706, a Novel Tyrosine Kinase Inhibitor (TKI), in Healthy Subjects and in Subjects with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Cortes, Jorge
CO-338-043: ARIEL4 (Assessment of Rucaparib In Ovarian CancEr TriaL): A Phase 3 Multicenter, Randomized Study of Rucaparib versus Chemotherapy in Patients with Relapsed, BRCA-Mutant, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Ghamande, Sharad
COA Measurement Evaluation in Progressive Supranuclear Palsy Morgan, John
Coming out: Parent's and Children's Perspectives. Taylor, Mark
Comparative effectiveness of biofeedback, sacral nerve stimulation, and injectable bulking agents for the treatment of fecal incontinence Rao, Satish
Comparing BMD results between two similar DEXA systems Harris, Ryan
Comparing number of injection sites of in-office intravesical Onabotulinumtoxin A treatments for overactive bladder: a randomized controlled trial Lanzer, Jennifer
Comprehensive Weight Control Program Dobosz, Thomas
Congenital Heart Disease Project to Understand Lifelong Survivor Experience (CHD PULSE) St Louis, James
Connect® MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry Mian, Mohammad
CSF flow rate through cerebral aqueduct as an approximation for CSF production and absorption determined by MRI techniques Macomson, Samuel
CT7001: A Modular, Multipart, Multiarm, Open-label, Phase I/IIa Study to Evaluate the Safety and Tolerability of CT7001 Alone and in Combination with Anti-cancer Treatments in Patients with Advanced Malignancies Krutchik, Allan
D-Dimer Assay, A Possible Tool in the Evaluation of Atrial Thrombosis Robinson, Vincent
D081RC00001 A Phase III Randomised, Double-Blind, Placebo-Controlled, Multicentre Study of Durvalumab in Combination with Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib in Newly Diagnosed Advanced Ovarian Cancer Patients (DUO-O) Ghamande, Sharad
D18-11141: Phase III Randomized Trial of DFP-10917 vs. Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Venetoclax Combination Regimens) or Intensive Reinduction (High and Intermediate Dose Cytarabine Regimens) for Acute Myelogenous Leukemia Patients in Second, Third, or Fourth Salvage Cortes, Jorge
D910FC00001: An Open-Label, Multi-Center, Global Study to Evaluate Long Term Safety and Efficacy in Patients Who are Receiving or Who Previously Received Durvalumab in Other Protocols (WAVE) Parikh, Jigarkumar
DEFINE: A Phase 4, Randomized, Active-Controlled, Open-label Study to Evaluate the Safety and Tolerability of Switching to Once Daily Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-dose Combination (FDC) Regimen in Virologically-suppressed Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Experiencing Rapid Weight Gain with an INI+TAF/FTC-Based ARV Regimen Newman, Cheryl
Development and psychometric evaluation of a brain fogginess symptoms questionnaire: The BFSQ Rao, Satish
Development of a patient centered primary and secondary prevention intervention for breast and ovarian cancer in African American women Vernon, Marlo
Developmental Gene Discovery Project: Mapping and Identifying New Genes in Uterine and Vaginal Development; Identifying New Genes Causing Birth Defects in Children Layman, Lawrence
Differences in Postural Control during the Single-Limb Romanian Deadlift using the Dominant vs Non-Dominant Limb during Weighted and Weighted Conditions Hogan, Valerie
DISRUPT CF-301-105: A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of Exebacase in Adult Patients Receiving Standard-of-Care Antibiotics for the Treatment of Staphylococcus aureus Bloodstream Infections (Bacteremia), Including Right-Sided Infective Endocarditis Vazquez, Jose
Do Compression Garments Influence the Slow Component of VO2 during a Long Distance Run? Craig-Jones, Andrew
Does Fatigue Affect Ground Reaction Forces during Landing? Craig-Jones, Andrew
EA1131 A Randomized Phase III Post Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy Ghamande, Sharad
EDP-938-103: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effects of EDP-938 in Adult Hematopoietic Cell Transplant Recipients With Acute Respiratory Syncytial Virus Infection of the Upper Respiratory Tract Chao, Andrew
Effect of Nutritional Status on APOL1 Variants – Chronic Kidney Disease (Pilot Study) Anglin, Judith
Emperor Reduced: A phase III randomized, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10mg compared to placebo, in patients with chronic Heart Failure and reduced Ejection Fraction (HFrEF) Dunlap, Stephanie
EP0057-201: A Phase 2 study to evaluate the safety and efficacy of EP0057 in combination with Olaparib in advanced ovarian cancer patients who have: Cohort 1 – platinum resistant disease and are PARP inhibitor naïve; Cohort 2 – had at least 2 prior lines of therapy which must include at least 1 line of platinum-based chemotherapy followed by PARP inhibitor maintenance. Ghamande, Sharad
Estrogen mediated vascular endothelial dysfunction in Diabetes Harris, Ryan
Evaluating Patient-Reported Outcomes Monitoring in Routine Care of Patients with Chronic Myeloid Leukemia for Increasing Adherence and Clinical Response to Therapy: The EMPATHY Pilot Study Kota, Vamsi
Evaluation of colonic pressure activity, topographic mapping with colonic transit and evacuation using Fecobionics- a simulated electronic stool, in subjects with constipation and control subjects Rao, Satish
Examining Media Frames and Biases in Coverage of Transgendered Athletes Hopkins, Ashley
Exploring the Influence of Clinician Biases on the Diagnoses of African Americans Patients Johnson, Michelle
Facial Recognition Software to Identify Facial Features that Predict Difficulty of Mask Ventilation and Intubation. Rocuts Martinez, Klifford
FGCL-4592-082: A Phase 3 Randomized Double-Blind Placebo-Controlled Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Patients with Lower Risk Myelodysplastic Syndrome (MDS) with Low Red Blood Cell (RBC) Transfusion Burden (LTB) Cortes, Jorge
FITE19: Evaluation of the Efficacy and Safety of PTC299 in Hospitalized Subjects with COVID-19 (PTC299-VIR-015-COV19) Vazquez, Jose
FPA150-001: A Phase 1a/1b Study of FPA150, an Anti-B7-H4 Antibody, in Patients with Advanced Solid Tumors Ghamande, Sharad
FURI: Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 in Patients with Fungal Diseases that are Refractory to or Intolerant of Standard Antifungal Treatment (SCY-078-301) Vazquez, Jose
GCC2020: Repurposing ibrutinib for chemo-immunotherapy in a phase 1b study of ibrutinib with indoximod plus metronomic cyclophosphamide and etoposide for pediatric patients with brain cancer Johnson, Theodore
GCT1015-05/GOG 3024: A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax® -TF -ADC) in Combination with Other Agents in Subjects with Recurrent or Stage IVB Cervical Cancer Ghamande, Sharad
Genetics of Delayed Puberty/ Genes Important in Puberty, Dual Functions of WDR11 in the Pathogenesis of Hypogonadotrophic Hypogonadism Layman, Lawrence
Georgetown STUDY00003849: A phase II trial of combination therapy of pembrolizumab and lenvatinib in patients with locally advanced or metastatic cervical cancer Ghamande, Sharad
Georgia CF Center Longitudinal Phenotyping (CFP30-P) Harris, Ryan
Gilead GS-US-200-4334: A Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhibitor GS-6207 in Combination with Other Antiretroviral Agents in People Living with HIV Newman, Cheryl
Ground Reaction Forces during Distracted Landing Craig-Jones, Andrew
GS-US-380-4030: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching from a Regimen of Dolutegravir and Either Emtricitabine/ Tenofovir Alafenamide or Emtricitabine/Tenofovir Disoproxil Fumarate to a Fixed Dose Combination of Bictegravir/ Emtricitabine/Tenofovir Alafenamide in HIV‑1 Infected Subjects who are Virologically Suppressed Newman, Cheryl
GS-US-380-4580: A Phase 3b, Multicenter, Open-Label Study to Evaluate Switching From a Regimen of Two Nucleos(t)ide Reverse Transcriptase Inhibitors (NRTI) plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants Newman, Cheryl
GSK 205744: A Phase I/II, open-label, 2 arm study to investigate the safety, clinical activity, pharmacokinetics, and pharmacodynamics of GSK2879552 administered alone or in combination with azacitidine, in adult subjects with IPSS-R high and very high risk myelodysplastic syndromes (MDS) previous treated with hypomethylating agents (HMA) Pantin, Jeremy
Health benefits of home based whole-body vibration (VIBE-Rx) Harris, Ryan
Home biofeedback therapy for dyssynergic defecation, fecal incontinence, and urinary incontinence: Randomized study Rao, Satish
Human Milk in Preterm Infants Wynter, Zanna
Humeral Retroversion, Range of Motion, and Strength Adaptations in Tennis Players Hannah, Daniel
Identification of novel biomarker in osteoarthritis knee Fulzele, Sadanand
Identification of TGF beta regulated proteins in aqueous humor Sharma, Ashok
Immunogenicity, Compliance, Knowledge and Attitudes in Postpartum Women during a Two Dose 9-valent HPV Vaccination Series Zahler-Miller, Carolyn
Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening In Transgender Men Theisen, John
Improving Cognition via Exercise in Schizophrenia McEvoy, Joseph
INCMGA 0012-204: An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) Ghamande, Sharad
Influenza Vaccination in Schizophrenia Miller, Brian
InformCLL: A Disease Registry for Patients with Chronic Lymphocytic Leukemia Bryan, Locke
Insomnia and Pupillometry in Schizophrenia Miller, Brian
Intermittent Fasting in Tactical Athletes Holland, Angelia
Investigation of supplemental L-alanine in the management of dietary fructose intolerance: a double-blind, randomized study Rao, Satish
JZP025-101: V-FAST: A Phase 1b Master Trial to Investigate CPX-351 Combined with Various Targeted Agents in Subjects with Previously Untreated Acute Myeloid Leukemia Study Cortes, Jorge
K017-119 VITORA: A Randomized, Open-Label, Prospective, Parallel Group, 2-Part Clinical Food Study to Assess the Safety, Tolerability, and Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts are Colonized with Multiple Drug-resistant Organisms Vazquez, Jose
Kadmon KD025-013: A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study) Kota, Vamsi
Knowledge Translation of Remotely Delivered Task Oriented Training for Stroke Rehabilitation (reTOTE- Remote Task Oriented Training and Evaluation) Carrick, Ryan
KRT-232-117: An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined with a Tyrosine Kinase Inhibitor (TKI) in Patients with Relapsed or Refractory Ph+ Chronic Myeloid Leukemia (CML) Cortes, Jorge
LAI116482: A Phase IIb, dose ranging study of oral GSK1265744 in combination with nucleoside reverse transcriptase inhibitors for induction of HIV-1 virologic suppression followed by an evaluation of maintenance of virologic suppression when oral GSK1265744 is combined with oral rilpivirine in HIV-1 infected, antiretroviral therapy naive adult subjects Newman, Cheryl
Language Development in Preterm Infants Williams, Bryan
Leadership Processes During the COVID-19 Pandemic: Implications for Preparation and Training Workman, Joseph
Long-Term Nicotine Treatment of Mild Cognitive Impairment Morgan, John
Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies Rivner, Michael
M16-191: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib in Subjects with Myelofibrosis (TRANSFORM-1) Cortes, Jorge
M20-178: A Randomized, Open-Label, Phase 3 Study Evaluating Efficacy and Safety of Navitoclax in Combination with Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/Refractory Myelofibrosis (TRANSFORM-2) Cortes, Jorge
Measuring Time-Dependent Pupillary Light Reflex Variables McCall, William
Mechanisms Regulating Aquaporin 3 Expression in Keratinocytes and the Epidermis Bollag, Wendy
MEI-011: A Two-Stage, Open-Label Followed by Placebo Controlled Phase 2 Study of Pracinostat and Azacitidine in Patients with IPSS-R High and Very High Risk Myelodysplastic Syndromes Previously Untreated with Hypomethylating Agents Pantin, Jeremy
MER-XMT-1536-1/GOG 3048: A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b Ghamande, Sharad
Metformin and Lorcaserin for Weight Loss in People with Schizophrenia McEvoy, Joseph
MK-8591A-018: A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate a Switch to Doravirine/Islatravir (DOR/ISL) Once-Daily in Participants With HIV-1 Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Newman, Cheryl
MORAb-003-011: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination with Carboplatin plus Paclitaxel or Carboplatin plus Pegylated Liposomal Doxorubicin (PLD) in Subjects with Low CA125 Platinum-Sensitive Ovarian Cancer Ghamande, Sharad
MORAb-202-G000-201: A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability, and Efficacy of MORAb-202, a folate receptor alpha (FR?)-targeting antibody-drug conjugate (ADC) in Subjects With Selected Tumor Types Ghamande, Sharad
MS200647_0046 Safety Study of Bintrafusp alfa in Combination with Other Anti-cancer Therapies in Participants with Locally Advanced or Advanced Cervical Cancer Ghamande, Sharad
MS201943-0029: A Phase Ib, Safety Run-in and Randomized Phase II, Open-label Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of M6620 in Combination with Avelumab and Carboplatin in Comparison to Standard of Care Therapy in Participants with PARPi-resistant Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer. Ghamande, Sharad
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment with NLY01 in Early-stage Parkinson’s Disease Morgan, John
Newborn Biorepository Stansfield, Brian
NKTR 16-214-05 (PROPEL) - A PHASE 1/2, OPEN-LABEL, MULTICENTER STUDY TO INVESTIGATE THE SAFETY AND PRELIMINARY EFFICACY OF COMBINED BEMPEGALDESLEUKIN (NKTR-214) AND PEMBROLIZUMAB WITH OR WITHOUT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS Raval, Girindra
NMTRC 014: NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO) McDonough, Colleen
NMTRC012: PEDS-PLAN--Pediatric Precision Laboratory Advanced Neuroblastoma Therapy - A study using molecular guided therapy with induction chemotherapy followed by a randomized controlled trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for subjects with newly diagnosed high-risk neuroblastoma McDonough, Colleen
Normative and Comparative Data of Anorectal Physiology and Morphology using 3D Anal Ultrasound, Translumbar Nerve Conduction, 3D HD Manometry and Anal Endo-Flip in Healthy Volunteers Sharma, Amol
NRG-GY009; A Randomized, Phase II/III Study of Pegylated Lipsomal Doxorubicin and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer Ghamande, Sharad
ONO-7475-01: A Phase I/II open label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary clinical efficacy of ONO-7475 in patients with acute leukemias or myelodysplastic syndromes Cortes, Jorge
ONT-380-206: Phase 2 Randomized, Double-Blinded, Controlled Study of ONT-380 vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma Ghamande, Sharad
Patellofemoral Pain and Knee Osteoarthritis: When are Degenerative Changes Apparent Bolgla, Lori
PerkinElmer® COVID-19 Antigen Test Clinical Evaluation Study (Non-Prescription Home Use) Kolhe, Ravindra
Phase 2 trial of indoximod with chemotherapy and radiation for children with progressive brain tumors or newly diagnosed DIPG Johnson, Theodore
Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Dipraglurant (ADX48621) for the Treatment of Dyskinesia in Patients with Parkinson's Disease Receiving Levodopa-based Therapy With or Without Concomitant Dopaminergic Medications Morgan, John
Phase I Study to Determine the Safety and Tolerability of Escalating Doses of Panobinostat (LBH589) in Patients with Sickle Cell Disease Kutlar, Abdullah
Phenome and Genome of Diabetes Autoimmunity (PAGODA): 1. High-Throughput Confirmation of Serum Biomarkers for Type 1 Diabetes; 2. Development of Microarray-Based Biomarkers for Type 1 Diabetes Sharma, Ashok
Physical activity-based asset-map of an underserved neighborhood in CSRA: Perceptions from neighborhood leaders. Pinkerton, Brittany
Physiological responses to myofascial release intra-resistance exercise Greene, Daniel
Pilot Studies in Pupillometry in Suicidal and non-Suicidal Patients McCall, Vaughn
Pilot study of the impact of antidepressant treatment on the pupillary light reflex and heart rate variability in depressed adults McCall, William
PNH Registry Kutlar, Abdullah
POLAR 209035: A Phase IIb, Multicenter, Open-label, Rollover Study Evaluating the Efficacy, Safety and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months in HIV-1 infected Adults who are Virologically Suppressed and Participated in Study LAI116482 (Pro00025197) Newman, Cheryl
Ponatinib-3001: A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib versus Imatinib, Administered in Combination with Reduced-intensity Chemotherapy, in Patients with Newly Diagnosed Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) Kota, Vamsi
PrE0404: A Phase I/II Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Bryan, Locke
PrE0905: Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML) Kota, Vamsi
PREEMPT CRC: Prevention of Colorectal Cancer Through Multiomics Blood Testing Vega, Kenneth
Preoperative education in Head and Neck Cancer Patients undergoing free flap reconstruction Morgan, Patrick
PRIDE Functional and Translational Genomics of Blood Disorders Pace, Betty
Professional Identity and Reviewing for Writing Center Journals Bond, Candis
PROSPECT: Prospective Study for Symptomatic Relief of Essential Tremor with Cala Therapy Morgan, John
Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries Kota, Vamsi
Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries Kota, Vamsi
PRT543-01: A Phase I, Open-Label, Multicenter, Dose Escalation, Dose Expansion Study of PRT543 in Patients with Advanced Solid Tumors and Hematologic Malignancies Cortes, Jorge
PRT811-01: A Phase 1, Open-Label, Multicenter, Dose Escalation and Expansion Study of PRT811 in Subjects with Advanced Solid Tumors and Recurrent High-Grade Gliomas Henson, John
Psychological Flexibility and Changes in Functioning in an Acceptance and Commitment Therapy Group for Stage 2 DBT Patients House, Amy
R10933-10987-COV-2067: A Master Protocol Assessing the Safety, Tolerability and Efficacy of Anti-SPIKE(s) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19 Vazquez, Jose
RAINBOW study: a randomized, controlled study evaluating the efficacy and safety of RAnibizumab compared with laser therapy for the treatment of Infants Born prematurely With retinopathy of prematurity Bhatia, Jatinder
RBC Deformability in Acute Stroke Singh, Dilip
REMAP-CAP: Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP): COVID-19 (REMAP-COVID) / RCC2116 Vazquez, Jose
ReSTORE: A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety of Rezafungin for Injection versus Intravenous Caspofungin Followed by Optional Oral Fluconazole Step-down in the Treatment of Subjects with Candidemia and/or Invasive Candidiasis Vazquez, Jose
Retrospective Review of Head and Neck Cancer Patients Byrd, J. Kenneth
Role of blood flow on artery function and exercise capacity in cystic fibrosis (CF-FLOW) Harris, Ryan
Role of skeletal muscle health on poor lifestyle related type 2 diabetes and cardiovascular disease risk Wang, Xiaoling
Role of Social Determinants of Health and Vascular Aging as Markers of Cardiovascular Disease due to Cancer Therapy Guha, Avirup
Rostock International Parkinson’s Disease Study - An international, multicentre, epidemiological observational study Morgan, John
S1605; Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Ghamande, Sharad
S1827, “MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)” Ghamande, Sharad
S1929, “Phase II Randomized Study of Maintenance Atezolizumab versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC)” Raval, Girindra
S1933, “A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status” Abdel-Karim, Nagla
SARS2 SeroPrevalence And Respiratory Tract Assessment (SPARTA) Kolhe, Ravindra
SARS2 SeroPrevalence And Respiratory Tract Assessment (SPARTA) (COVID-19) Kolhe, Ravindra
Schizophrenia Research Database McEvoy, Joseph
Serum measurement of Donor-derived cell-free DNA (dd-cfDNA) for early detection of allograft rejection in Pediatric Kidney Transplants: A Single Center Experience Mirza, Ahmad
SGN22E-001: A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy Parikh, Jigarkumar
SGNTUC-016: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02) Raval, Priyanka
SGNTV-002 - Open Label Phase 2 Study of Tisotumab Vedotin for Patients with Platinum-Resistant Ovarian Cancer with a Safety Run-in of a Dose-Dense Regimen Ghamande, Sharad
SGNTV-003/GOG 3057: A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator’s Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer Ghamande, Sharad
Sickle Cell Disease Implementation Consortium (SCDIC) Registry Kutlar, Abdullah
SLSG18-301: A Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monotherapy Compared to Investigator's Choice of Best Available Therapy in Subjects with Acute Myeloid Leukemia Who Have Achieved Complete Remission After Second-Line Salvage Therapy Cortes, Jorge
SOFAST: SOFia Aspiration System as first line Technique Rahimi, Scott
Stigma in Psychotic Disorders: Relationships with Insight, Resilience, and Social and Occupational Functioning McEvoy, Joseph
Studies on Epidemiology and Risk Indicators of Peri-Implantitis El-Awady, Ahmed
Study to evaluate the safety, tolerability, and efficacy of ganglioside administration for neurodegenerative diseases Itokazu, Yutaka
Studying the feasibility and acceptability of an interactive web-based lethal means safety decision aid for hospitalized suicidal adults (Lock to Live). McCall, Vaughn
TAEK-VAC-HerBy-001: Phase 1/2 expansion cohorts trial of intravenous administration of TAEK-VAC-HerBy vaccine alone and in combination with HER2- and PD-1/PD-L1 antibodies in patients with advanced HER2-expressing cancer Raval, Priyanka
TAS1553-01: A Phase 1 Study of Safety, Pharmacokinetics and Preliminary Activity of TAS1553 in Subjects with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms Cortes, Jorge
TESARO 4010-01-001: A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors Ghamande, Sharad
The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients with Hematologic Disease Kutlar, Abdullah
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease Annex, Brian
The Association between Humeral Retroversion and Shoulder Strength on Throwing Velocity and Elbow Varus Torque in Recreational Overhead Athletes Hannah, Daniel
The association between length and number of deployments on the emotional health and behavior of children and adolescents in military families Londino, Donna
The effects of early mobilization on inflammatory cytokines in critically ill pediatric patients: a pilot study Mathew, Smitha
The effects of task familiarity and training status on subjective time perception during exercise Moore, Andrew
The Impact of COVID 19 on Laryngeal Function, Voice, Communication and Quality of Life Postma, Gregory
The influence of an acute bout of exercise on cognitive performance among obese and healthy adults Jehu, Deborah
The Influence of Body Position (Lying, Sitting, and Squatting) on Defecation Dynamics Rao, Satish
The influence of the Otago Exercise Program on executive function among older adults living with dementia Jehu, Deborah
The International Randomised Controlled Trial of Two Forms of Electroconvulsive Therapy (ECT) for Severe Depression: Focal Electrically Administered Seizure Therapy (FEAST) and Right Unilateral Ultrabrief ECT McCall, William
The psychological and physiological outcomes of virtual reality exercise Greene, Daniel
The Randomised Controlled Trial of Frontoparietal and Temporoparietal Electroconvulsive Therapy (ECT) for Severe Depression: The RAFT ECT Study McCall, William
The Roles of HMB and Sodium in Blood Pressure Regulation and Gut Microbiome Chen, Li
The ShOP Study (Shopping in Older Adults Project) Lehman, Leigh
Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study Sharma, Amol
TL-895-202: A Phase 1/2, Double-Blind, Randomized, Placebo-Controlled Study of TL-895 with Standard Available Treatment versus Standard Available Treatment for the Treatment of COVID-19 in Patients with Cancer Cortes, Jorge
Translational Research in Benign and Malignant Genitourinary, Gastrointestinal, and Breast Diseases. Lokeshwar, Vinata
TRANSLUMBOSACRAL NEUROMODULATION THERAPY FOR FECAL INCONTINENCE: RANDOMIZED TRIAL Rao, Satish
Treatment of acne in pregnancy Potter, Kathryn
Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life: A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents (SUMMIT) Bryan, Locke
TRX518-004: A Dose Escalation and Expansion Study of TRX518 in Combination with Cyclophosphamide Plus Avelumab in Advanced Solid Tumors Nayak-Kapoor, Asha
Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1 (T-St1M) Harris, Ryan
Understanding the Genetic Basis of Transgender Identity Layman, Lawrence
Using a humanized mouse model to predict which potential living donor is immunologically the best match for a prospective living donor kidney transplant recipient. Mulloy, Laura
Using Appraisal Theory to Help Graduate Students Improve Writing Skills Zhao, Jun
Utility of Olfactory Training in patients with Chronic Rhinosinusitis with Nasal Polyps Reyes-Gelves , Camilo
Utility of Pre-Operative Stellate Ganglion Blockade for Pain Control in Unilateral Head and Neck Cancer Surgery Byrd, Kenneth
VA Rheumatoid Arthritis Registry Le, Brian
Vascular Risk of Cancer (V-ROC) Harris, Ryan
VT3996-201: A Phase 1b/2 Open-Label, Dose Escalation and Expansion Study of Orally Administered VRx-3996 and Valganciclovir in Subjects with Epstein-Barr Virus-Associated Lymphoid Malignancies Bryan, Locke
WO42017 - A PHASE II, SAFETY, AND EFFICACY STUDY OF TIRAGOLUMAB PLUS ATEZOLIZUMAB AND ATEZOLIZUMAB MONOTHERAPY IN PATIENTS WITH METASTATIC AND/OR RECURRENT PD-L1 POSITIVE CERVICAL CANCER Ghamande, Sharad
Xience 90 Study Kapoor, Deepak
RESEARCH. INNOVATION. DISCOVERY.